Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Where can you publish?
Find journals in COLORADO Profiles by department and year.

Contact Us
If you have any questions or feedback please contact us.

Larry Alexander Allen

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-4713

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Flint KM, Spertus JA, Tang F, Jones P, Fendler TJ, Allen LA. Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation. BMC Cardiovasc Disord. 2017 Mar 14; 17(1):78.
      View in: PubMed
    2. Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Khazanie P, Lindrooth R, Peterson PN. The Affordable Care Act Medicaid Expansion Correlated With Increased Heart Transplant Listings in African-Americans But Not Hispanics or Caucasians. JACC Heart Fail. 2017 Feb; 5(2):136-147.
      View in: PubMed
    3. Piccini JP, Allen LA. Heart Failure Complicated by Atrial Fibrillation: Don't Bury the Beta-Blockers Just Yet. JACC Heart Fail. 2017 Feb; 5(2):107-109.
      View in: PubMed
    4. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. JACC Heart Fail. 2017 Jan; 5(1):44-52.
      View in: PubMed
    5. Allen LA, Matlock DD, Shetterly SM, Xu S, Levy WC, Portalupi LB, McIlvennan CK, Gurwitz JH, Johnson ES, Smith DH, Magid DJ. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2016 Dec 21.
      View in: PubMed
    6. Narayan M, Jones J, Portalupi LB, McIlvennan CK, Matlock DD, Allen LA. Patient Perspectives on Communication of Individualized Survival Estimates in Heart Failure. J Card Fail. 2016 Dec 21.
      View in: PubMed
    7. McIlvennan CK, Wordingham SE, Allen LA, Matlock DD, Jones J, Dunlay SM, Swetz KM. Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians. J Card Fail. 2016 Dec 05.
      View in: PubMed
    8. Jurgens PT, Allen LA, Ambardekar AV, McIlvennan CK. Chronic Norovirus Infections in Cardiac Transplant Patients: Considerations for Evaluation and Management. Prog Transplant. 2016 Nov 23.
      View in: PubMed
    9. McIlvennan CK, Thompson JS, Matlock DD, Cleveland JC, Dunlay SM, LaRue SJ, Lewis EF, Patel CB, Walsh MN, Allen LA. A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data. J Cardiovasc Nurs. 2016 Nov/Dec; 31(6):E8-E20.
      View in: PubMed
    10. Orr NM, Boxer RS, Dolansky MA, Allen LA, Forman DE. Skilled Nursing Facility Care for Patients With Heart Failure: Can We Make It "Heart Failure Ready?" J Card Fail. 2016 Dec; 22(12):1004-1014.
      View in: PubMed
    11. Flint KM, Schmiege SJ, Allen LA, Fendler TJ, Rumsfeld J, Bekelman D. Health Status Trajectories Among Outpatients With Heart Failure. J Pain Symptom Manage. 2017 Feb; 53(2):224-231.
      View in: PubMed
    12. Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction. Circ Heart Fail. 2016 Oct; 9(10).
      View in: PubMed
    13. Bekelman DB, Allen LA, Peterson J, Hattler B, Havranek EP, Fairclough DL, McBryde CF, Meek PM. Rationale and study design of a patient-centered intervention to improve health status in chronic heart failure: The Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) randomized trial. Contemp Clin Trials. 2016 Nov; 51:1-7.
      View in: PubMed
    14. Randolph TC, Simon DN, Thomas L, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED, Piccini JP. Patient factors associated with quality of life in atrial fibrillation. Am Heart J. 2016 Dec; 182:135-143.
      View in: PubMed
    15. Arnold SV, Jones PG, Allen LA, Cohen DJ, Fendler TJ, Holtz JE, Aggarwal S, Spertus JA. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry. Circ Heart Fail. 2016 Aug; 9(8).
      View in: PubMed
    16. McIlvennan CK, Allen LA, Matlock DD. Caregiver Perspectives on End-of-Life Experiences of Patients With Left Ventricular Assist Devices-Reply. JAMA Intern Med. 2016 Aug 01; 176(8):1231-2.
      View in: PubMed
    17. Magid M, Mcllvennan CK, Jones J, Nowels CT, Allen LA, Thompson JS, Matlock D. Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis. Am Heart J. 2016 Oct; 180:64-73.
      View in: PubMed
    18. Allen LA, Ambardekar AV. Hashing It Out Over Cannabis: Moving Toward a Standard Guideline on Substance Use for Cardiac Transplantation Eligibility That Includes Marijuana. Circ Heart Fail. 2016 Jul; 9(7).
      View in: PubMed
    19. Khazanie P, Allen LA. Meta-Analysis of Medication Adherence Interventions Among Heart Failure Patients: The Lumpers Make Their Case. J Am Heart Assoc. 2016 Jun 17; 5(6).
      View in: PubMed
    20. Allen LA, McIlvennan CK. Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model? Am Heart J. 2016 Aug; 178:188-9.
      View in: PubMed
    21. Piccini JP, Simon DN, Steinberg BA, Thomas L, Allen LA, Fonarow GC, Gersh B, Hylek E, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Spertus JA, Peterson ED. Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry. JAMA Cardiol. 2016 Jun 01; 1(3):282-91.
      View in: PubMed
    22. Bui QM, Allen LA, Monte AA, Page RL, McIlvennan CK. Amphetamine-positive urine drug screens in the setting of mexiletine use: A case series. J Heart Lung Transplant. 2016 Aug; 35(8):1045-8.
      View in: PubMed
    23. Paine AM, Allen LA, Thompson JS, McIlvennan CK, Jenkins A, Hammes A, Kroehl M, Matlock DD. Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey. J Card Fail. 2016 Nov; 22(11):908-912.
      View in: PubMed
    24. Breathett K, Allen LA, Ambardekar AV. Patient-centered care for left ventricular assist device therapy: current challenges and future directions. Curr Opin Cardiol. 2016 May; 31(3):313-20.
      View in: PubMed
    25. Magid M, Jones J, Allen LA, McIlvennan CK, Magid K, Thompson JS, Matlock DD. The Perceptions of Important Elements of Caregiving for a Left Ventricular Assist Device Patient: A Qualitative Meta-Synthesis. J Cardiovasc Nurs. 2016 May-Jun; 31(3):215-25.
      View in: PubMed
    26. McIlvennan CK, Allen LA. Palliative care in patients with heart failure. BMJ. 2016 Apr 14; 353:i1010.
      View in: PubMed
    27. Hooker SA, Ross K, Masters KS, Park CL, Hale AE, Allen LA, Bekelman DB. Denver Spirited Heart: Mixed-Methods Pilot Study of a Psychospiritual Intervention for Heart Failure Patients. J Cardiovasc Nurs. 2016 Apr 12.
      View in: PubMed
    28. McIlvennan CK, Jones J, Allen LA, Swetz KM, Nowels C, Matlock DD. Bereaved Caregiver Perspectives on the End-of-Life Experience of Patients With a Left Ventricular Assist Device. JAMA Intern Med. 2016 Apr; 176(4):534-9.
      View in: PubMed
    29. Piccini JP, Allen LA, Kudenchuk PJ, Page RL, Patel MR, Turakhia MP. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association. Circulation. 2016 Apr 26; 133(17):1715-27.
      View in: PubMed
    30. Ahmad T, Desai N, Wilson F, Schulte P, Dunning A, Jacoby D, Allen L, Fiuzat M, Rogers J, Felker GM, O'Connor C, Patel CB. Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles. PLoS One. 2016; 11(2):e0145881.
      View in: PubMed
    31. McIlvennan CK, Allen LA. Quality of Life After Left Ventricular Assist Device Implantation: In a World Full of Data, #Missingness. J Card Fail. 2016 May; 22(5):338-9.
      View in: PubMed
    32. Warraich HJ, Allen LA, Mukamal KJ, Ship A, Kociol RD. Accuracy of physician prognosis in heart failure and lung cancer: Comparison between physician estimates and model predicted survival. Palliat Med. 2016 07; 30(7):684-9.
      View in: PubMed
    33. Kociol RD, Allen LA. Gradual Increases in Scheduled and Actual Early Follow-Up After Heart Failure Hospitalization: Two Steps Forward or One Step Forward? Circ Heart Fail. 2016 Jan; 9(1).
      View in: PubMed
    34. Thompson JS, Matlock DD, McIlvennan CK, Jenkins AR, Allen LA. Development of a Decision Aid for Patients With Advanced Heart Failure Considering a Destination Therapy Left Ventricular Assist Device. JACC Heart Fail. 2015 Dec; 3(12):965-76.
      View in: PubMed
    35. Allen LA, Fonarow GC, Liang L, Schulte PJ, Masoudi FA, Rumsfeld JS, Ho PM, Eapen ZJ, Hernandez AF, Heidenreich PA, Bhatt DL, Peterson ED, Krumholz HM. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures. Circulation. 2015 Oct 06; 132(14):1347-53.
      View in: PubMed
    36. Lum HD, Jones J, Lahoff D, Allen LA, Bekelman DB, Kutner JS, Matlock DD. Unique challenges of hospice for patients with heart failure: A qualitative study of hospice clinicians. Am Heart J. 2015 Sep; 170(3):524-30.e3.
      View in: PubMed
    37. Fendler TJ, Swetz KM, Allen LA. Team-based Palliative and End-of-life Care for Heart Failure. Heart Fail Clin. 2015 Jul; 11(3):479-98.
      View in: PubMed
    38. Allen LA, Fonarow GC, Simon DN, Thomas LE, Marzec LN, Pokorney SD, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Chang P, Peterson ED, Piccini JP. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. J Am Coll Cardiol. 2015 Jun 30; 65(25):2691-8.
      View in: PubMed
    39. Colvin M, Sweitzer NK, Albert NM, Krishnamani R, Rich MW, Stough WG, Walsh MN, Westlake Canary CA, Allen LA, Bonnell MR, Carson PE, Chan MC, Dickinson MG, Dries DL, Ewald GA, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Moore S, Rodgers JE, Rogers JG, Vest AR, Whellan DJ, Givertz MM. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee. J Card Fail. 2015 Aug; 21(8):674-93.
      View in: PubMed
    40. Thompson LE, Bekelman DB, Allen LA, Peterson PN. Patient-reported outcomes in heart failure: existing measures and future uses. Curr Heart Fail Rep. 2015 Jun; 12(3):236-46.
      View in: PubMed
    41. Chifamba J, Mbangani B, Chimhete C, Gwaunza L, Allen LA, Chinyanga HM. Vasomotor sympathetic outflow in the muscle metaboreflex in low birth weight young adults. Integr Blood Press Control. 2015; 8:37-42.
      View in: PubMed
    42. DeVore AD, Allen LA, Eapen ZJ. Thinking Outside the Box: Treating Acute Heart Failure Outside the Hospital to Improve Care and Reduce Admissions. J Card Fail. 2015 Aug; 21(8):667-73.
      View in: PubMed
    43. McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015 May 19; 131(20):1796-803.
      View in: PubMed
    44. Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, Dickinson MG, Levy P, Stough WG, Sweitzer NK, Teerlink JR, Whellan DJ, Albert NM, Krishnamani R, Rich MW, Walsh MN, Bonnell MR, Carson PE, Chan MC, Dries DL, Hernandez AF, Hershberger RE, Katz SD, Moore S, Rodgers JE, Rogers JG, Vest AR, Givertz MM. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. J Card Fail. 2015 Jun; 21(6):519-34.
      View in: PubMed
    45. Fendler TJ, Spertus JA, Gosch KL, Jones PG, Bruce JM, Nassif ME, Flint KM, Dunlay SM, Allen LA, Arnold SV. Incidence and predictors of cognitive decline in patients with left ventricular assist devices. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):285-91.
      View in: PubMed
    46. Iacovetto MC, Allen LA. Transitioning into a digital world: Time for providers to recommend Internet health information? Am Heart J. 2015 Jul; 170(1):1-2.
      View in: PubMed
    47. Magid KH, Matlock DD, Thompson JS, McIlvennan CK, Allen LA. The influence of expected risks on decision making for destination therapy left ventricular assist device: An MTurk survey. J Heart Lung Transplant. 2015 Jul; 34(7):988-90.
      View in: PubMed
    48. McIlvennan CK, Jones J, Allen LA, Lindenfeld J, Swetz KM, Nowels C, Matlock DD. Decision-making for destination therapy left ventricular assist devices: implications for caregivers. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):172-8.
      View in: PubMed
    49. McIlvennan CK, Matlock DD, Narayan MP, Nowels C, Thompson JS, Cannon A, Bradley WJ, Allen LA. Perspectives from mechanical circulatory support coordinators on the pre-implantation decision process for destination therapy left ventricular assist devices. Heart Lung. 2015 May-Jun; 44(3):219-24.
      View in: PubMed
    50. Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, Hylek EM, Mahaffey KW, Freeman JV, Chang P, Holmes DN, Peterson ED, Piccini JP, Gersh BJ. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015 May; 169(5):647-654.e2.
      View in: PubMed
    51. Allen LA. Simultaneous use of intravenous fluids and diuretics in patients hospitalized with heart failure: when the left hand does not know what the right hand is doing. JACC Heart Fail. 2015 Feb; 3(2):134-5.
      View in: PubMed
    52. Gurwitz JH, Magid DJ, Smith DH, Hsu G, Sung SH, Allen LA, McManus DD, Goldberg RJ, Go AS. The complex relationship of race to outcomes in heart failure with preserved ejection fraction. Am J Med. 2015 Jun; 128(6):591-600.
      View in: PubMed
    53. McIlvennan CK, Allen LA. Outcomes in acute heart failure: 30-day readmission versus death. Curr Heart Fail Rep. 2014 Dec; 11(4):445-52.
      View in: PubMed
    54. Iacovetto MC, Matlock DD, McIlvennan CK, Thompson JS, Bradley W, LaRue SJ, Allen LA. Educational resources for patients considering a left ventricular assist device: a cross-sectional review of internet, print, and multimedia materials. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7(6):905-11.
      View in: PubMed
    55. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014 Nov; 7(6):1003-13.
      View in: PubMed
    56. D'souza RS, Levandowski C, Slavov D, Graw SL, Allen LA, Adler E, Mestroni L, Taylor MR. Danon disease: clinical features, evaluation, and management. Circ Heart Fail. 2014 Sep; 7(5):843-9.
      View in: PubMed
    57. O'Brien EC, Simon DN, Allen LA, Singer DE, Fonarow GC, Kowey PR, Thomas LE, Ezekowitz MD, Mahaffey KW, Chang P, Piccini JP, Peterson ED. Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014 Oct; 168(4):487-94.
      View in: PubMed
    58. Flint KM, Allen LA, Pham M, Heidenreich PA. B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes. J Am Heart Assoc. 2014 Jun 10; 3(3):e000806.
      View in: PubMed
    59. Allen LA, Rumsfeld JS. Can we predict who will be alive and well after transcatheter aortic valve replacement? Is that useful to individual patients? Circulation. 2014 Jun 24; 129(25):2636-7.
      View in: PubMed
    60. McIlvennan CK, Allen LA, Nowels C, Brieke A, Cleveland JC, Matlock DD. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot". Circ Cardiovasc Qual Outcomes. 2014 May; 7(3):374-80.
      View in: PubMed
    61. Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ. Performance of claims-based algorithms for identifying heart failure and cardiomyopathy among patients diagnosed with breast cancer. Med Care. 2014 May; 52(5):e30-8.
      View in: PubMed
    62. Chifamba J, Mapfumo C, Mawoneke DW, Gwaunza LT, Allen LA, Chinyanga HM. Exercise-induced cardiac fatigue in low and normal birth weight young black adults. Cardiol Young. 2015 Mar; 25(3):481-4.
      View in: PubMed
    63. Flint KM, Allen LA. Getting a grip on frailty: handgrip strength in patient selection for left ventricular assist device. J Card Fail. 2014 May; 20(5):316-8.
      View in: PubMed
    64. Allen LA, Ambardekar AV, Devaraj KM, Maleszewski JJ, Wolfel EE. Clinical problem-solving. Missing elements of the history. N Engl J Med. 2014 Feb 06; 370(6):559-66.
      View in: PubMed
    65. Allen LA, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Peterson PN, Partovian C, Li SX, Heidenreich PA, Heidenrich PA, Bhatt DL, Peterson ED, Krumholz HM. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines. Circ Heart Fail. 2014 Mar 01; 7(2):251-60.
      View in: PubMed
    66. McIlvennan CK, Allen LA. To DT or not to DT, that is the question: working toward a comprehensive, patient-centered perspective on left ventricular assist device for destination therapy. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):13-4.
      View in: PubMed
    67. O'Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, Gersh BJ, Fonarow GC, Koller CR, Ezekowitz MD, Mahaffey KW, Chang P, Peterson ED, Piccini JP, Singer DE. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2014 Apr; 167(4):601-609.e1.
      View in: PubMed
    68. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014 Mar 04; 63(8):747-62.
      View in: PubMed
    69. Allen LA, Shetterly SM, Peterson PN, Gurwitz JH, Smith DH, Brand DW, Fairclough DL, Rumsfeld JS, Masoudi FA, Magid DJ. Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail. 2014 Jan; 7(1):43-50.
      View in: PubMed
    70. Clarke CL, Grunwald GK, Allen LA, Barón AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):680-6.
      View in: PubMed
    71. Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM. Practice-level variation in use of recommended medications among outpatients with heart failure: Insights from the NCDR PINNACLE program. Circ Heart Fail. 2013 Nov; 6(6):1132-8.
      View in: PubMed
    72. Flint KM, Matlock DD, Sundareswaran KS, Lindenfeld J, Spertus JA, Farrar DJ, Allen LA. Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant. 2013 Dec; 32(12):1249-54.
      View in: PubMed
    73. Hess PL, Kim S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Fonarow GC. Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation. Am J Med. 2013 Jul; 126(7):625-32.e1.
      View in: PubMed
    74. Allen LA, Magid DJ, Gurwitz JH, Smith DH, Goldberg RJ, Saczynski J, Thorp ML, Hsu G, Sung SH, Go AS. Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail. 2013 Jul; 6(4):635-46.
      View in: PubMed
    75. Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013 May 01; 6(3):333-42.
      View in: PubMed
    76. Allen LA, Ambardekar AV. Diff'rent strokes, different folks: advanced heart failure's changing outlook. Circ Heart Fail. 2013 May; 6(3):355-7.
      View in: PubMed
    77. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013 May; 6(3):606-19.
      View in: PubMed
    78. Hersh AM, Masoudi FA, Allen LA. Postdischarge environment following heart failure hospitalization: expanding the view of hospital readmission. J Am Heart Assoc. 2013 Apr 11; 2(2):e000116.
      View in: PubMed
    79. Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013 May; 126(5):393-400.
      View in: PubMed
    80. Matlock DD, Allen LA. Defibrillators, deactivation, decisions, and dying. JAMA Intern Med. 2013 Mar 11; 173(5):375-94.
      View in: PubMed
    81. Bapoje SR, Bahia A, Hokanson JE, Peterson PN, Heidenreich PA, Lindenfeld J, Allen LA, Masoudi FA. Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials. Circ Heart Fail. 2013 Mar; 6(2):166-73.
      View in: PubMed
    82. Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, Allen LA. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013 Mar 01; 6(2):171-7.
      View in: PubMed
    83. Saczynski JS, Go AS, Magid DJ, Smith DH, McManus DD, Allen L, Ogarek J, Goldberg RJ, Gurwitz JH. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013 Jan; 61(1):26-33.
      View in: PubMed
    84. Vigen R, Maddox TM, Allen LA. Aging of the United States population: impact on heart failure. Curr Heart Fail Rep. 2012 Dec; 9(4):369-74.
      View in: PubMed
    85. Allen LA, Spertus JA. End points for comparative effectiveness research in heart failure. Heart Fail Clin. 2013 Jan; 9(1):15-28.
      View in: PubMed
    86. Allen LA, Smoyer Tomic KE, Smith DM, Wilson KL, Agodoa I. Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure. Circ Heart Fail. 2012 Nov; 5(6):672-9.
      View in: PubMed
    87. Allen LA, Smoyer Tomic KE, Wilson KL, Smith DM, Agodoa I. The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ. 2013; 16(1):43-54.
      View in: PubMed
    88. Partovian C, Gleim SR, Mody PS, Li SX, Wang H, Strait KM, Allen LA, Lagu T, Normand SL, Krumholz HM. Hospital patterns of use of positive inotropic agents in patients with heart failure. J Am Coll Cardiol. 2012 Oct 09; 60(15):1402-9.
      View in: PubMed
    89. Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 05; 104(17):1293-305.
      View in: PubMed
    90. Allen LA, Magid DJ, Zeng C, Peterson PN, Clarke CL, Shetterly S, Brand DW, Masoudi FA. Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization. BMC Cardiovasc Disord. 2012 Jun 18; 12:43.
      View in: PubMed
    91. Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol. 2012 May 15; 59(20):1799-808.
      View in: PubMed
    92. Fitzgerald AA, Allen LA, Masoudi FA. The evolving landscape of quality measurement for heart failure. Ann N Y Acad Sci. 2012 Apr; 1254:131-9.
      View in: PubMed
    93. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012 Apr 17; 125(15):1928-52.
      View in: PubMed
    94. Flint KM, Matlock DD, Lindenfeld J, Allen LA. Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail. 2012 Mar 01; 5(2):286-93.
      View in: PubMed
    95. Peterson PN, Campagna EJ, Maravi M, Allen LA, Bull S, Steiner JF, Havranek EP, Dickinson LM, Masoudi FA. Acculturation and outcomes among patients with heart failure. Circ Heart Fail. 2012 Mar 01; 5(2):160-6.
      View in: PubMed
    96. Bekelman DB, Nowels CT, Retrum JH, Allen LA, Shakar S, Hutt E, Heyborne T, Main DS, Kutner JS. Giving voice to patients' and family caregivers' needs in chronic heart failure: implications for palliative care programs. J Palliat Med. 2011 Dec; 14(12):1317-24.
      View in: PubMed
    97. Allen LA. End-point selection for acute heart failure trials. Heart Fail Clin. 2011 Oct; 7(4):481-95.
      View in: PubMed
    98. Lemond L, Allen LA. Palliative care and hospice in advanced heart failure. Prog Cardiovasc Dis. 2011 Sep-Oct; 54(2):168-78.
      View in: PubMed
    99. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9.
      View in: PubMed
    100. Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):389-98.
      View in: PubMed
    101. Bekelman DB, Nowels CT, Allen LA, Shakar S, Kutner JS, Matlock DD. Outpatient palliative care for chronic heart failure: a case series. J Palliat Med. 2011 Jul; 14(7):815-21.
      View in: PubMed
    102. Rumsfeld JS, Allen LA. Reducing readmission rates: Does coronary artery bypass graft surgery provide clarity? JACC Cardiovasc Interv. 2011 May; 4(5):577-8.
      View in: PubMed
    103. Peterson PN, Shetterly SM, Clarke CL, Bekelman DB, Chan PS, Allen LA, Matlock DD, Magid DJ, Masoudi FA. Health literacy and outcomes among patients with heart failure. JAMA. 2011 Apr 27; 305(16):1695-701.
      View in: PubMed
    104. Allen LA. Observational process-outcome associations for real-world ambulatory heart failure care: moving toward clarity, or clouding the view? Circulation. 2011 Apr 19; 123(15):1581-3.
      View in: PubMed
    105. Allen LA, Hernandez AF, Peterson ED, Curtis LH, Dai D, Masoudi FA, Bhatt DL, Heidenreich PA, Fonarow GC. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011 May; 4(3):293-300.
      View in: PubMed
    106. Allen LA, Felker GM. Multi-marker strategies in heart failure: clinical and statistical approaches. Heart Fail Rev. 2010 Jul; 15(4):343-9.
      View in: PubMed
    107. Allen LA. Use of multiple biomarkers in heart failure. Curr Cardiol Rep. 2010 May; 12(3):230-6.
      View in: PubMed
    108. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol. 2010 Jun 15; 105(12):1794-7.
      View in: PubMed
    109. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010 Jul; 29(7):771-6.
      View in: PubMed
    110. Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, Zannad F, Maggioni AP, Swedberg K, Konstam MA, Spertus JA. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010 Apr; 12(4):367-74.
      View in: PubMed
    111. Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC, Lindenfeld J, Brieke A, Sauer WH. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010 Apr; 16(4):327-31.
      View in: PubMed
    112. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010 Mar; 16(3):230-8.
      View in: PubMed
    113. Allen LA, Anstrom KJ, Horton JR, Shaw LK, Eisenstein EL, Felker GM. Relationship between anemia and health care costs in heart failure. J Card Fail. 2009 Dec; 15(10):843-9.
      View in: PubMed
    114. Allen LA, Hernandez AF, O'Connor CM, Felker GM. End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol. 2009 Jun 16; 53(24):2248-58.
      View in: PubMed
    115. Allen LA, Granger CB. Risk assessment in the genomic era: are we missing the low-hanging fruit? Am Heart J. 2009 May; 157(5):799-801.
      View in: PubMed
    116. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009 Feb; 11(2):170-7.
      View in: PubMed
    117. Havranek EP, Allen LA. Listening to patients. J Am Coll Cardiol. 2008 Nov 18; 52(21):1709-10.
      View in: PubMed
    118. Allen LA, Metra M, Milo-Cotter O, Filippatos G, Reisin LH, Bensimhon DR, Gronda EG, Colombo P, Felker GM, Cas LD, Kremastinos DT, O'Connor CM, Cotter G, Davison BA, Dittrich HC, Velazquez EJ. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF). J Card Fail. 2008 Nov; 14(9):777-84.
      View in: PubMed
    119. Allen LA, Rogers JG, Warnica JW, Disalvo TG, Tasissa G, Binanay C, O'Connor CM, Califf RM, Leier CV, Shah MR, Stevenson LW. High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. J Card Fail. 2008 Oct; 14(8):661-9.
      View in: PubMed
    120. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC, O'Connor CM, Felker GM. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008 Jun 04; 299(21):2533-42.
      View in: PubMed
    121. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol. 2008 May; 23(3):249-53.
      View in: PubMed
    122. Allen LA, Jolicoeur EM, Melloni C, Lopes RD, Chan MY, Majidi M, Piccini JP, Berger JS, Katz JN, Shah BR. Highlights from American Heart Association, November 4-7, 2007, Orlando, Florida, USA. Late-breaking trials summary. Am Heart J. 2008 Apr; 155(4):615-23.
      View in: PubMed
    123. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics. 2008; 26(6):447-62.
      View in: PubMed
    124. Adams GL, Mills JS, Melloni C, Allen LA, Jolicoeur EM, Wang T, Chan M, Majidi M, Lopes RD. Highlights from the 56th annual scientific sessions of the American College of Cardiology: March 25 to 27, 2007, Atlanta, Georgia. Am Heart J. 2007 Aug; 154(2):247-59.
      View in: PubMed
    125. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 03; 50(1):40-7.
      View in: PubMed
    126. Allen LA, O'Connor CM. Management of acute decompensated heart failure. CMAJ. 2007 Mar 13; 176(6):797-805.
      View in: PubMed
    127. Allen LA, O'Donnell CJ, Camargo CA, Giugliano RP, Lloyd-Jones DM. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J. 2006 May; 151(5):1065-71.
      View in: PubMed
    128. Allen LA, O'Donnell CJ, Giugliano RP, Camargo CA, Lloyd-Jones DM. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol. 2004 May 15; 93(10):1218-22.
      View in: PubMed
    129. Lloyd-Jones DM, Camargo CA, Allen LA, Giugliano RP, O'Donnell CJ. Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol. 2003 Nov 15; 92(10):1155-9.
      View in: PubMed
    130. Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, Jobling MG, Rapoport T, Holmes RK, Lencer WI. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm. Mol Biol Cell. 2003 Dec; 14(12):4783-93.
      View in: PubMed
    131. Allen LA. The role of the neutrophil and phagocytosis in infection caused by Helicobacter pylori. Curr Opin Infect Dis. 2001 Jun; 14(3):273-7.
      View in: PubMed
    132. Allen LA, Woolfolk RL, Lehrer PM, Gara MA, Escobar JI. Cognitive behavior therapy for somatization disorder: a preliminary investigation. J Behav Ther Exp Psychiatry. 2001 Jun; 32(2):53-62.
      View in: PubMed
    133. Gallois A, Klein JR, Allen LA, Jones BD, Nauseef WM. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol. 2001 May 01; 166(9):5741-8.
      View in: PubMed
    134. Allen LA, Gara MA, Escobar JI, Waitzkin H, Silver RC. Somatization: a debilitating syndrome in primary care. Psychosomatics. 2001 Jan-Feb; 42(1):63-7.
      View in: PubMed
    135. Gara MA, Allen LA, Herzog EP, Woolfolk RL. The abused child as parent: the structure and content of physically abused mothers' perceptions of their babies. Child Abuse Negl. 2000 May; 24(5):627-39.
      View in: PubMed
    136. Allen LA. Modulating phagocyte activation: the pros and cons of Helicobacter pylori virulence factors. J Exp Med. 2000 May 01; 191(9):1451-4.
      View in: PubMed
    137. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med. 2000 Jan 03; 191(1):115-28.
      View in: PubMed
    138. DeLeo FR, Allen LA, Apicella M, Nauseef WM. NADPH oxidase activation and assembly during phagocytosis. J Immunol. 1999 Dec 15; 163(12):6732-40.
      View in: PubMed
    139. Allen LA. Intracellular niches for extracellular bacteria: lessons from Helicobacter pylori. J Leukoc Biol. 1999 Nov; 66(5):753-6.
      View in: PubMed
    140. Allen LA, DeLeo FR, Gallois A, Toyoshima S, Suzuki K, Nauseef WM. Transient association of the nicotinamide adenine dinucleotide phosphate oxidase subunits p47phox and p67phox with phagosomes in neutrophils from patients with X-linked chronic granulomatous disease. Blood. 1999 May 15; 93(10):3521-30.
      View in: PubMed
    141. Allen LA. Treating agitation without drugs. Am J Nurs. 1999 Apr; 99(4):36-41; quiz 42.
      View in: PubMed
    142. Burke PV, Raitt DC, Allen LA, Kellogg EA, Poyton RO. Effects of oxygen concentration on the expression of cytochrome c and cytochrome c oxidase genes in yeast. J Biol Chem. 1997 Jun 06; 272(23):14705-12.
      View in: PubMed
    143. Fieldman NP, Woolfolk RL, Allen LA. Dimensions of self-concept: a comparison of heroin and cocaine addicts. Am J Drug Alcohol Abuse. 1995 Aug; 21(3):315-26.
      View in: PubMed
    144. Allen LA, Zhao XJ, Caughey W, Poyton RO. Isoforms of yeast cytochrome c oxidase subunit V affect the binuclear reaction center and alter the kinetics of interaction with the isoforms of yeast cytochrome c. J Biol Chem. 1995 Jan 06; 270(1):110-8.
      View in: PubMed
    145. Poyton RO, Goehring B, Droste M, Sevarino KA, Allen LA, Zhao XJ. Cytochrome-c oxidase from Saccharomyces cerevisiae. Methods Enzymol. 1995; 260:97-116.
      View in: PubMed
    Allen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
    Physical Neighbors
    _

    Copyright © 2012 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.5.1)